Skip to content

South San Francisco, CA, September 12, 2022 – FlemingMartin is pleased to announce that ORIC Pharmaceuticals, a clinical stage biopharmaceutical company focused on developing precision medicines targeting cancer resistance mechanisms, has hired Dan Iazzetti as Vice President, Head of People.

Dan possesses 20+ years of experience developing and driving HR strategy and execution in the biopharmaceutical industry. Throughout his career, Dan has served as a trusted advisor and coach to senior leaders, particularly in the areas of workforce planning, talent acquisition, HR operations, and compliance. Dan excels in building relationships and guiding companies through change. Moreover, Dan is passionate about working in fast-paced, purpose-driven environments where people are a top priority, innovation is fully embraced, and growth and development are wholly supported.

Over the past two decades, Dan has thrived in a number of top life sciences companies representing different sizes and stages of maturity. Most recently, Dan served as Senior Vice President of Human Resources at Angion Biomedica Corp. (NASDAQ: ANGN), where he held responsibility for building out an HR function to support the company’s transformation from a private business to a publicly traded company. Previously, Dan held HR and Talent Acquisition leadership roles of increasing scope at Five Prime Therapeutics (acquired by Amgen for $1.9B), Actelion Pharmaceuticals (acquired by Johnson & Johnson for $30B), ZS Pharma (acquired by AstraZeneca for $2.7B), and Gilead Sciences (NASDAQ: GILD). Dan earned his BS in Psychology from Marist University in his native New York.


Oric Pharmaceuticals Logo ORIC Pharma (NASDAQ: ORIC) is a clinical stage company dedicated to discovering, developing, and commercializing novel therapies that can Overcome Resistance In Cancer. ORIC is leveraging specialized expertise in hormone dependent cancers, precision oncology, and key tumor dependencies to build a portfolio of novel agents targeting multiple resistance mechanisms in cancer cells.


Fleming Martin Color Logo Medium 72 Ppi 300X65 1 FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, Private Equity Firms and CEOs of companies to build successful execution-focused management teams. FlemingMartin focuses on the Life Sciences, Technology, and Financial Services industries. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital.